These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 5348411

  • 1. [Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].
    Gaillard JM, Schaeppi R, Tissot R.
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):423-37. PubMed ID: 5348411
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].
    Matussek N, Benkert O, Schneider K, Otten H, Pohlmeier H.
    Arzneimittelforschung; 1970 Jul; 20(7):934-5. PubMed ID: 4918921
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of large doses of L-DOPA on the cerebral electrical activity of rabbits (interaction with the metabolism of 5-HT)].
    Gaillard JM, Friedli P, Tissot R.
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):342-52. PubMed ID: 4694370
    [No Abstract] [Full Text] [Related]

  • 4. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM, Parks LC, Kopin IJ.
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [Abstract] [Full Text] [Related]

  • 5. [Selective increase of C14-catecholamines in the brain due to peripheral inhibition of decarboxylase].
    Bartholini G, Pletscher A, Burkard WP.
    Helv Physiol Pharmacol Acta; 1967 Jun; 25(2):CR170-2. PubMed ID: 5588156
    [No Abstract] [Full Text] [Related]

  • 6. Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase.
    Bartholini G, Da Prada M, Pletscher A.
    J Pharm Pharmacol; 1968 Mar; 20(3):228-9. PubMed ID: 4385052
    [No Abstract] [Full Text] [Related]

  • 7. Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase.
    Bartholini G, Burkard WP, Pletscher A.
    Nature; 1967 Aug 19; 215(5103):852-3. PubMed ID: 6049735
    [No Abstract] [Full Text] [Related]

  • 8. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E, Kleinrok Z.
    Psychopharmacologia; 1972 Aug 19; 23(3):279-88. PubMed ID: 4260342
    [No Abstract] [Full Text] [Related]

  • 9. Modification of the cardiovascular effects of L-dopa in anesthetized dogs by inhibitors of enzymes involved in catecholamine metabolism.
    Robson RD.
    Circ Res; 1971 Jun 19; 28(6):662-70. PubMed ID: 4325846
    [No Abstract] [Full Text] [Related]

  • 10. Effect of L-dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes.
    Watanabe AM, Chase TN, Cardon PV.
    Clin Pharmacol Ther; 1970 Jun 19; 11(5):740-6. PubMed ID: 5455636
    [No Abstract] [Full Text] [Related]

  • 11. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
    Court J, Kase JC, Mena I, Palacios E.
    Rev Med Chil; 1973 Jun 19; 101(6):452-5. PubMed ID: 4764560
    [No Abstract] [Full Text] [Related]

  • 12. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
    Bartholini G, Pletscher A.
    J Pharmacol Exp Ther; 1968 May 19; 161(1):14-20. PubMed ID: 5648492
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Proceedings: Further studies on the mechanisms of blood pressure lowering effect of L-DOPA and a peripheral decarboxylase inhibitor in hypertensive rats.
    Nakamura K, Nakamura K.
    Jpn Heart J; 1974 Mar 19; 15(2):187-8. PubMed ID: 4546215
    [No Abstract] [Full Text] [Related]

  • 18. Hyperactive states related to the metabolism of norepinephrine and similar biochemicals.
    Scheckel CL, Boff E, Pazery LM.
    Ann N Y Acad Sci; 1969 Jul 30; 159(3):939-58. PubMed ID: 4981886
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.